Compare Stocks

Date Range: 

 Bristol-Myers SquibbAstraZenecaSanofiNovo Nordisk A/SEli Lilly and
SymbolNYSE:BMYNASDAQ:AZNNASDAQ:SNYNYSE:NVONYSE:LLY
Price Information
Current Price$64.46$53.48$51.01$74.20$193.89
52 Week RangeBuyBuyHoldHoldBuy
MarketRank™
Overall Score2.32.21.41.22.1
Analysis Score2.44.40.00.02.4
Community Score2.62.92.02.12.8
Dividend Score2.51.72.52.52.5
Ownership Score1.70.00.00.01.7
Earnings & Valuation Score2.51.92.51.31.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$74.33$99.33N/AN/A$200.75
% Upside from Price Target15.32% upside85.74% upsideN/AN/A3.54% upside
Trade Information
Market Cap$143.93 billion$140.36 billion$128.44 billion$174.73 billion$185.95 billion
Beta0.670.550.550.460.37
Average Volume12,382,98210,822,6722,261,740977,9114,062,586
Sales & Book Value
Annual Revenue$26.15 billion$24.38 billion$40.00 billion$18.30 billion$22.32 billion
Price / Sales5.515.763.219.558.33
Cashflow$4.25 per share$3.30 per share$7.06 per share$2.96 per share$7.40 per share
Price / Cash15.1616.217.2325.1026.19
Book Value$23.20 per share$5.56 per share$26.44 per share$3.65 per share$2.81 per share
Price / Book2.789.621.9320.3369.00
Profitability
Net Income$3.44 billion$1.34 billion$3.26 billion$5.84 billion$8.32 billion
EPS$4.69$1.75$3.32$2.46$6.04
Trailing P/E RatioN/A55.7121.8027.8931.68
Forward P/E Ratio8.8120.5713.6425.0724.30
P/E Growth1.001.181.902.211.57
Net Margins-0.11%9.65%14.49%32.65%24.01%
Return on Equity (ROE)27.48%37.23%24.77%71.46%166.45%
Return on Assets (ROA)10.77%8.30%13.28%31.34%15.18%
Dividend
Annual Payout$1.96$1.86$1.35$1.33$3.40
Dividend Yield3.04%3.48%2.65%1.79%1.75%
Three-Year Dividend Growth46.79%N/A3.58%13.65%42.31%
Payout Ratio41.79%106.29%40.66%54.07%56.29%
Years of Consecutive Dividend Growth1 YearsN/A1 Years1 Years1 Years
Debt
Debt-to-Equity Ratio0.82%1.34%0.32%0.04%3.27%
Current Ratio1.67%0.96%1.85%1.04%1.36%
Quick Ratio1.58%0.76%1.38%0.78%1.06%
Ownership Information
Institutional Ownership Percentage72.41%15.57%6.93%5.91%75.59%
Insider Ownership Percentage0.14%N/A1.00%0.07%0.09%
Miscellaneous
Employees30,25076,10099,41244,72335,000
Shares Outstanding2.23 billion2.62 billion2.52 billion2.35 billion959.03 million
Next Earnings Date8/5/2021 (Estimated)7/29/2021 (Estimated)8/4/2021 (Estimated)8/5/2021 (Estimated)7/29/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Lilly to donate 400,000 doses of COVID-19 treatment therapy to IndiaLilly to donate 400,000 doses of COVID-19 treatment therapy to India
wishtv.com - May 6 at 6:52 PM
Eli Lilly Donates COVID-19 Treatments To India, Other Countries Around The WorldEli Lilly Donates COVID-19 Treatments To India, Other Countries Around The World
indianapublicmedia.org - May 6 at 1:52 PM
Lilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetesLilly collaborates internationally with leading diabetes technology companies to integrate connected insulin pen solutions for people with diabetes
wfmz.com - May 6 at 8:52 AM
Glooko Announces Digital Health Collaboration with Eli Lillys Connected Insulin Pen Solutions in Global MarketsGlooko Announces Digital Health Collaboration with Eli Lilly's Connected Insulin Pen Solutions in Global Markets
markets.businessinsider.com - May 6 at 8:52 AM
Eli Lilly responds to issues raised by FDA inspection, employee complaintEli Lilly responds to issues raised by FDA inspection, employee complaint
fox59.com - May 5 at 10:49 PM
Lilly hit by staff accusations, FDA scrutiny at COVID drug factoriesLilly hit by staff accusations, FDA scrutiny at COVID drug factories
in.finance.yahoo.com - May 5 at 5:48 PM
Eli Lilly Under FDA Scrutiny At Its COVID-19 Drug Manufacturing Facilities Amid Staff Accusations: ReutersEli Lilly Under FDA Scrutiny At Its COVID-19 Drug Manufacturing Facilities Amid Staff Accusations: Reuters
finance.yahoo.com - May 5 at 5:48 PM
AmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of ExpectationsAmerisourceBergen Stock Dives After Q2 Earnings Fall Short Of Expectations
finance.yahoo.com - May 5 at 5:48 PM
Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factoriesExclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
msn.com - May 5 at 12:28 PM
Eli Lilly faces employee complaints, FDA troubles at factory making COVID-19 drug: reportEli Lilly faces employee complaints, FDA troubles at factory making COVID-19 drug: report
fiercepharma.com - May 5 at 12:28 PM
Why Eli Lilly Is Still a Top Stock for 2021Why Eli Lilly Is Still a Top Stock for 2021
msn.com - May 5 at 12:28 PM
Jim Cramer: Eli Lilly stock represents real valueJim Cramer: Eli Lilly stock represents real value
msn.com - May 4 at 11:17 PM
Eli Lilly and (NYSE:LLY) to Repurchase $5.00 billion in   SharesEli Lilly and (NYSE:LLY) to Repurchase $5.00 billion in Shares
americanbankingnews.com - May 4 at 10:12 PM
Eli Lilly to supply 400,000 tablets of its COVID-19 treatment to IndiaEli Lilly to supply 400,000 tablets of its COVID-19 treatment to India
reuters.com - May 4 at 6:17 PM
Lilly Announces Global Donations of COVID TreatmentsLilly Announces Global Donations of COVID Treatments
insideindianabusiness.com - May 4 at 6:17 PM
Was The Smart Money Right About Eli Lilly and Company (LLY)?Was The Smart Money Right About Eli Lilly and Company (LLY)?
finance.yahoo.com - May 4 at 6:17 PM
Eli Lilly and (NYSE:LLY) Releases FY 2021 Earnings GuidanceEli Lilly and (NYSE:LLY) Releases FY 2021 Earnings Guidance
americanbankingnews.com - May 4 at 3:22 PM
BRIEF-Lilly Plans Donation Of Covid-19 Therapies To Direct Relief For Use In Low- And Lower-Middle-Income CountriesBRIEF-Lilly Plans Donation Of Covid-19 Therapies To Direct Relief For Use In Low- And Lower-Middle-Income Countries
msn.com - May 4 at 1:16 PM
How Eli Lilly and Company Cracked an Inclusive Approach in Health CommunicationsHow Eli Lilly and Company Cracked an Inclusive Approach in Health Communications
adweek.com - May 4 at 1:16 PM
Lilly Donates COVID Therapy to IndiaLilly Donates COVID Therapy to India
insideindianabusiness.com - May 4 at 1:16 PM
Eli Lilly Donates 400,000 Tablets Of Covid-19 Drug To India, Plans To Scale Up Local ProductionEli Lilly Donates 400,000 Tablets Of Covid-19 Drug To India, Plans To Scale Up Local Production
forbes.com - May 4 at 1:16 PM
AbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human TrialsAbCellera-Lilly Partnered Second COVID-19 Antibody Enters Human Trials
finance.yahoo.com - May 4 at 1:16 PM
Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countriesLilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries
finance.yahoo.com - May 4 at 1:16 PM
Eli Lilly and (NYSE:LLY) Price Target Cut to $227.00 by Analysts at BarclaysEli Lilly and (NYSE:LLY) Price Target Cut to $227.00 by Analysts at Barclays
americanbankingnews.com - May 4 at 11:44 AM
Eli Lilly and (NYSE:LLY) Price Target Lowered to $216.00 at MizuhoEli Lilly and (NYSE:LLY) Price Target Lowered to $216.00 at Mizuho
americanbankingnews.com - May 4 at 11:12 AM
Wall Street logs gains Monday on strong earningsWall Street logs gains Monday on strong earnings
marketbeat.com - May 3 at 11:39 AM
Wall Street logs early gains Monday on strong earningsWall Street logs early gains Monday on strong earnings
marketbeat.com - May 3 at 10:34 AM
Wall Street opening higher Monday on strong earningsWall Street opening higher Monday on strong earnings
marketbeat.com - May 3 at 9:56 AM
World shares mixed after retreat on Wall StreetWorld shares mixed after retreat on Wall Street
marketbeat.com - May 3 at 5:24 AM
Asian shares mostly lower; China, Japan closed for holidaysAsian shares mostly lower; China, Japan closed for holidays
marketbeat.com - May 2 at 11:56 PM
Stocks pull below record but still end best month this yearStocks pull below record but still end best month this year
marketbeat.com - April 30 at 4:15 PM
Stocks move lower, still head for 3rd straight monthly gainStocks move lower, still head for 3rd straight monthly gain
marketbeat.com - April 30 at 1:22 PM
The Latest: Brazils COVID-19 death toll tops 400,000The Latest: Brazil's COVID-19 death toll tops 400,000
marketbeat.com - April 29 at 6:18 PM
The Latest: Pfizer to ship vaccine in smaller packagesThe Latest: Pfizer to ship vaccine in smaller packages
marketbeat.com - April 29 at 5:45 PM
The Latest: Study: About 1/3 in Mexico showed virus exposureThe Latest: Study: About 1/3 in Mexico showed virus exposure
marketbeat.com - April 29 at 5:14 PM
The Latest: New Mexico to encourage people to return to workThe Latest: New Mexico to encourage people to return to work
marketbeat.com - April 29 at 4:19 PM
The Latest: Incentives help some Americans get vaccinatedThe Latest: Incentives help some Americans get vaccinated
marketbeat.com - April 29 at 2:00 PM
The Latest: Macron: France to reopen cafes, museums May 19The Latest: Macron: France to reopen cafes, museums May 19
marketbeat.com - April 29 at 12:40 PM
Eli Lilly and (NYSE:LLY) Given New $207.00 Price Target at Morgan StanleyEli Lilly and (NYSE:LLY) Given New $207.00 Price Target at Morgan Stanley
marketbeat.com - April 28 at 10:36 AM
Slipping COVID-19 treatment demand hits Eli Lilly forecastSlipping COVID-19 treatment demand hits Eli Lilly forecast
marketbeat.com - April 27 at 9:09 AM
The Latest: Decreasing demand for vaccines in KansasThe Latest: Decreasing demand for vaccines in Kansas
marketbeat.com - April 16 at 5:08 PM
The Latest: Infections in Turkey soar to record levelsThe Latest: Infections in Turkey soar to record levels
marketbeat.com - April 16 at 1:55 PM
The Latest: WH: $4B to American Indian tribes for virusThe Latest: WH: $4B to American Indian tribes for virus
marketbeat.com - April 16 at 1:08 PM
The Latest: US sets up $1.7B network to track virus variantsThe Latest: US sets up $1.7B network to track virus variants
marketbeat.com - April 16 at 12:38 PM
The Latest: Eli Lilly: Antibody combo works best on variantsThe Latest: Eli Lilly: Antibody combo works best on variants
marketbeat.com - April 16 at 10:36 AM
3 Recession-Proof Dividend Stocks to Buy Now (LLY)3 Recession-Proof Dividend Stocks to Buy Now (LLY)
marketbeat.com - February 1 at 5:14 PM
Follow Eli Lillys (NYSE:LLY) Lead, and Make a  Big PurchaseFollow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase
marketbeat.com - December 15 at 11:42 AM
How to Invest After a Turbulent 2020 Election (LLY)How to Invest After a Turbulent 2020 Election (LLY)
marketbeat.com - November 23 at 5:51 PM
DateCompanyBrokerageAction
5/6/2021Bristol-Myers SquibbMorgan StanleyReiterated Rating
4/19/2021Bristol-Myers SquibbTruist SecuritiesUpgrade
4/13/2021Bristol-Myers SquibbTruist FinancialUpgrade
12/15/2020Bristol-Myers SquibbThe Goldman Sachs GroupUpgrade
11/30/2020Bristol-Myers SquibbCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
11/30/2020Bristol-Myers SquibbSmith Barney CitigroupBoost Price Target
11/16/2020Bristol-Myers SquibbSociete GeneraleUpgrade
11/10/2020Bristol-Myers SquibbSanford C. BernsteinReiterated Rating
11/6/2020Bristol-Myers SquibbGabelliDowngrade
10/19/2020Bristol-Myers SquibbGuggenheimUpgrade
10/16/2020Bristol-Myers SquibbJPMorgan Chase & Co.Boost Price Target
9/29/2020Bristol-Myers SquibbBerenberg BankInitiated Coverage
9/25/2020Bristol-Myers SquibbRaymond JamesReiterated Rating
7/28/2020Bristol-Myers SquibbSeaport Global SecuritiesInitiated Coverage
7/26/2020Bristol-Myers SquibbCfraReiterated Rating
6/2/2020Bristol-Myers SquibbCantor FitzgeraldBoost Price Target
6/1/2020Bristol-Myers SquibbWilliam BlairReiterated Rating
5/15/2020Bristol-Myers SquibbBank of AmericaReiterated Rating
4/19/2021AstraZenecaArgusReiterated Rating
3/22/2021AstraZenecaJefferies Financial GroupUpgrade
3/18/2021AstraZenecaDeutsche Bank AktiengesellschaftReiterated Rating
3/8/2021AstraZenecaBarclaysReiterated Rating
3/8/2021AstraZenecaSVB LeerinkLower Price Target
3/3/2021AstraZenecaUBS GroupUpgrade
12/30/2020AstraZenecaAlphaValueUpgrade
12/13/2020AstraZenecaPiper SandlerLower Price Target
11/11/2020AstraZenecaHSBCUpgrade
9/23/2020AstraZenecaOddo BhfUpgrade
8/19/2020SanofiStifel NicolausDowngrade
2/7/2020SanofiDZ BankReiterated Rating
1/22/2020SanofiLiberum CapitalDowngrade
1/20/2021Novo Nordisk A/SCredit Suisse GroupDowngrade
5/4/2020Novo Nordisk A/SCowenInitiated Coverage
11/22/2019Novo Nordisk A/SPareto SecuritiesDowngrade
5/4/2021Eli Lilly andMizuhoLower Price Target
12/10/2020Eli Lilly andWolfe ResearchUpgrade
(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.